Michael Goldsmith
Stock Analyst at UBS
(2.78)
# 2,607
Out of 5,032 analysts
420
Total ratings
45.6%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Michael Goldsmith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELS Equity LifeStyle Properties | Reiterated: Buy | $67 | $58.37 | +14.78% | 14 | Oct 6, 2026 | |
| SUI Sun Communities | Reiterated: Hold | $127 → $117 | $111.55 | +4.89% | 15 | Oct 6, 2026 | |
| LINE Lineage | Reiterated: Hold | $45 | $33.95 | +32.55% | 7 | Sep 29, 2026 | |
| CPT Camden Property Trust | Reiterated: Hold | $106 → $105 | $96.40 | +8.92% | 15 | Sep 15, 2026 | |
| BXP BXP, Inc. | Rated: Hold | $61 → $70 | $58.88 | +18.89% | 8 | Aug 25, 2026 | |
| AHR American Healthcare REIT | Rated: Buy | $63 | $49.86 | +26.35% | 6 | Aug 21, 2026 | |
| DOC Healthpeak Properties | Rated: Hold | $22 | $18.87 | +13.94% | 4 | Aug 21, 2026 | |
| HR Healthcare Realty Trust | Rated: Hold | $21 | $17.05 | +23.17% | 4 | Aug 21, 2026 | |
| OHI Omega Healthcare Investors | Rated: Buy | $54 | $44.47 | +21.44% | 6 | Aug 21, 2026 | |
| SBRA Sabra Health Care REIT | Rated: Hold | $21 | $19.00 | +10.53% | 6 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $93 | $80.87 | +15.00% | 5 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $271 | $223.69 | +21.15% | 8 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $73 | $59.80 | +22.07% | 7 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $65.74 | +38.42% | 12 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 | $18.50 | +8.11% | 8 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $43 | $37.58 | +14.44% | 14 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $58 | $54.75 | +5.95% | 8 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 | $25.49 | +56.92% | 12 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $163 | $132.92 | +22.63% | 22 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $21.14 | +41.91% | 7 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 | $27.80 | +18.71% | 8 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $40.35 | +11.52% | 12 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 | $17.50 | +37.14% | 8 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $72 | $54.05 | +33.21% | 9 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 | $17.65 | +10.48% | 7 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $326 | $284.99 | +14.39% | 20 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $63.76 | +17.63% | 8 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $27.10 | +36.53% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $127 | $105.04 | +20.91% | 17 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $21.97 | +32.03% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 | $23.99 | +25.05% | 6 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $37.26 | +23.46% | 6 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $71.13 | +19.50% | 13 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $222 | $199.89 | +11.06% | 19 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $19.42 | +23.58% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $132 | $115.55 | +14.24% | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $278 | $270.16 | +2.90% | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 → $16 | $13.78 | +16.11% | 4 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $32 → $35 | $30.13 | +16.16% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $35 | $26.21 | +33.54% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $148 → $161 | $127.45 | +26.32% | 9 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $48 | $36.26 | +32.38% | 3 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $42 | $33.48 | +25.45% | 6 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $380 | $550.64 | n/a | 13 | May 17, 2021 |
Equity LifeStyle Properties
Oct 6, 2026
Reiterated: Buy
Price Target: $67
Current: $58.37
Upside: +14.78%
Sun Communities
Oct 6, 2026
Reiterated: Hold
Price Target: $127 → $117
Current: $111.55
Upside: +4.89%
Lineage
Sep 29, 2026
Reiterated: Hold
Price Target: $45
Current: $33.95
Upside: +32.55%
Camden Property Trust
Sep 15, 2026
Reiterated: Hold
Price Target: $106 → $105
Current: $96.40
Upside: +8.92%
BXP, Inc.
Aug 25, 2026
Rated: Hold
Price Target: $61 → $70
Current: $58.88
Upside: +18.89%
American Healthcare REIT
Aug 21, 2026
Rated: Buy
Price Target: $63
Current: $49.86
Upside: +26.35%
Healthpeak Properties
Aug 21, 2026
Rated: Hold
Price Target: $22
Current: $18.87
Upside: +13.94%
Healthcare Realty Trust
Aug 21, 2026
Rated: Hold
Price Target: $21
Current: $17.05
Upside: +23.17%
Omega Healthcare Investors
Aug 21, 2026
Rated: Buy
Price Target: $54
Current: $44.47
Upside: +21.44%
Sabra Health Care REIT
Aug 21, 2026
Rated: Hold
Price Target: $21
Current: $19.00
Upside: +10.53%
Aug 21, 2026
Rated: Hold
Price Target: $93
Current: $80.87
Upside: +15.00%
Aug 21, 2026
Rated: Buy
Price Target: $271
Current: $223.69
Upside: +21.15%
Aug 20, 2026
Rated: Buy
Price Target: $73
Current: $59.80
Upside: +22.07%
Aug 18, 2026
Reiterated: Buy
Price Target: $91
Current: $65.74
Upside: +38.42%
Aug 18, 2026
Rated: Hold
Price Target: $20
Current: $18.50
Upside: +8.11%
Aug 18, 2026
Rated: Hold
Price Target: $43
Current: $37.58
Upside: +14.44%
Aug 18, 2026
Rated: Hold
Price Target: $58
Current: $54.75
Upside: +5.95%
Aug 18, 2026
Rated: Buy
Price Target: $40
Current: $25.49
Upside: +56.92%
Aug 18, 2026
Rated: Buy
Price Target: $163
Current: $132.92
Upside: +22.63%
Aug 18, 2026
Rated: Buy
Price Target: $30
Current: $21.14
Upside: +41.91%
Aug 18, 2026
Rated: Hold
Price Target: $33
Current: $27.80
Upside: +18.71%
Aug 18, 2026
Rated: Hold
Price Target: $45
Current: $40.35
Upside: +11.52%
Aug 18, 2026
Rated: Buy
Price Target: $24
Current: $17.50
Upside: +37.14%
Aug 18, 2026
Rated: Buy
Price Target: $72
Current: $54.05
Upside: +33.21%
Aug 18, 2026
Rated: Hold
Price Target: $20
Current: $17.65
Upside: +10.48%
Aug 18, 2026
Rated: Hold
Price Target: $326
Current: $284.99
Upside: +14.39%
Aug 18, 2026
Rated: Hold
Price Target: $75
Current: $63.76
Upside: +17.63%
Aug 17, 2026
Reiterated: Buy
Price Target: $37
Current: $27.10
Upside: +36.53%
Aug 17, 2026
Reiterated: Hold
Price Target: $127
Current: $105.04
Upside: +20.91%
Aug 17, 2026
Reiterated: Buy
Price Target: $29
Current: $21.97
Upside: +32.03%
Aug 17, 2026
Reiterated: Hold
Price Target: $30
Current: $23.99
Upside: +25.05%
Aug 17, 2026
Reiterated: Hold
Price Target: $46
Current: $37.26
Upside: +23.46%
Aug 17, 2026
Reiterated: Hold
Price Target: $85
Current: $71.13
Upside: +19.50%
Aug 17, 2026
Reiterated: Hold
Price Target: $222
Current: $199.89
Upside: +11.06%
Aug 17, 2026
Reiterated: Hold
Price Target: $24
Current: $19.42
Upside: +23.58%
Aug 14, 2026
Rated: Hold
Price Target: $132
Current: $115.55
Upside: +14.24%
Aug 13, 2026
Rated: Hold
Price Target: $278
Current: $270.16
Upside: +2.90%
Jul 17, 2026
Rated: Hold
Price Target: $13 → $16
Current: $13.78
Upside: +16.11%
Jul 8, 2026
Rated: Hold
Price Target: $32 → $35
Current: $30.13
Upside: +16.16%
Jul 8, 2026
Rated: Buy
Price Target: $32 → $35
Current: $26.21
Upside: +33.54%
Apr 17, 2026
Rated: Buy
Price Target: $148 → $161
Current: $127.45
Upside: +26.32%
Feb 18, 2026
Reiterated: Buy
Price Target: $43 → $48
Current: $36.26
Upside: +32.38%
Jan 8, 2026
Reiterated: Buy
Price Target: $41 → $42
Current: $33.48
Upside: +25.45%
May 17, 2021
Reiterated: Buy
Price Target: $360 → $380
Current: $550.64
Upside: n/a